Oncology
Single screening for Lynch syndrome beats sequential tests in CRC
FROM JAMA ONCOLOGY Physicians could more accurately test patients with colon cancer for Lynch ...
Think about breast cancer surveillance for transgender patients
REPORTING FROM ENDO 2018 CHICAGO (FRONTLINE MEDICAL NEWS) – Both transgender men and transgender ...
Checkpoint inhibition less toxic than antiangiogenic therapy in NSCLC
REPORTING FROM THE NCCN ANNUAL CONFERENCE ORLANDO (FRONTLINE MEDICAL NEWS) – Checkpoint blockade is ...
FDA expands indication for blinatumomab in treating ALL
The Food and Drug Administration has granted accelerated approval to blinatumomab for treatment of ...
Oncologist-led BRCA mutation testing and counseling may reduce wait times for women with ovarian cancer
FROM THE JOURNAL OF CLINICAL ONCOLOGY For women with ovarian cancer, an oncologist-led BRCA1/2 ...
Ibrutinib plus venetoclax is active in mantle cell lymphoma
FROM THE NEW ENGLAND JOURNAL OF MEDICINE In mantle cell lymphoma (MCL), ibrutinib plus ...
Survival worse with alcohol-related HCC, compared with other types
FROM CANCER Hepatocellular carcinoma (HCC) related to alcohol use tends to be diagnosed at ...
HDAC inhibition may boost immune therapy efficacy in breast cancer
REPORTING FROM THE NCCN ANNUAL CONFERENCE ORLANDO (FRONTLINE MEDICAL NEWS) – The novel combination ...
Over one-third report financial burden from breast cancer treatment
REPORTING FROM SSO 2018 CHICAGO (FRONTLINE MEDICAL NEWS) – Women who have treatment for ...
CBC data can predict immunotherapy responses in NSCLC
REPORTING FROM THE NCCN ANNUAL CONFERENCE ORLANDO (FRONTLINE MEDICAL NEWS) – Information readily available ...
Lower socioeconomic status linked with poor NSCLC prognosis in those with pretreatment weight loss
FROM JOURNAL OF ONCOLOGY PRACTICE Socioeconomic status, as measured by insurance status, was associated ...
FDA approves nilotinib for children with CML
Nilotinib is now approved for use by children aged 1 year and older with ...
Chemotherapy, metabolic pathway may affect CAR T-cell potential
FROM AACR 2018 Two critical factors – prior exposure to chemotherapy and a glycolytic ...
